[시장보고서]세계의 스마트 인슐린 펜 시장 규모 : 제품 유형, 연결 유형, 용도, 유통 채널별

세계의 스마트 인슐린 펜 시장 규모 : 제품 유형, 연결 유형, 용도, 유통 채널별 - 지역별 전망, 경쟁 전략, 부문 예측(-2033년)

Smart Insulin Pens Market Size- By Product, By Connectivity Type, By Application, By Distribution Channel- Regional Outlook, Competitive Strategies and Segment Forecast to 2033

상품코드 : 1471947

리서치사 : SPER Market Research Pvt. Ltd.

발행일 : 2024년 04월

페이지 정보 : 영문 233 Pages

라이선스 & 가격 (부가세 별도)

US $ 4,250

￦ 6,140,000

Unprintable PDF (Single User License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 불가능하며 인용 시에는 출처를 명시해 주시기 바랍니다

US $ 5,650

￦ 8,163,000

PDF (Group License)

PDF 보고서를 동일 사업장에서 5명까지 이용할 수 있는 라이선스입니다. 인쇄는 5회까지 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다. 인용 시에는 출처를 명시해 주시기 바랍니다.

US $ 7,450

￦ 10,763,000

PDF (Company License)

PDF 및 Excel 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다. 인용 시에는 출처를 명시해 주시기 바랍니다.

한글목차

샘플 요청 목록에 추가

세계 스마트 인슐린 펜 시장 규모는 2033년까지 10.69%의 연평균 복합 성장률(CAGR)로 20억 5,411만 달러 규모로 성장할 것으로 예상됩니다.

코로나19로 인해 병원과 당뇨병 센터를 방문하는 환자가 줄어들면서 스마트 인슐린 펜 처방이 감소했습니다. 또한, 유통망 문제로 인해 소매점에서의 구매가 어려워져 판매량이 감소했습니다. 코로나19와 관련된 경기 침체로 인해 소비자들의 비용에 대한 인식이 높아지면서 고가의 인슐린 펜 시장이 축소되었습니다.

세계 스마트 인슐린 펜(Smart Insulin Pen) 시장을 조사했으며, 시장 개요, 시장 영향요인 및 시장 기회 분석, 시장 규모 추이 및 예측, 각종 부문별/지역별 상세 분석, 경쟁 구도, 주요 기업 개요 등의 정보를 정리하여 전해드립니다.

영문목차

Smart Insulin Pens Market Introduction and Overview

According to SPER market research, Smart Insulin Pens Market Size- By Product, By Connectivity Type, By Application, By Distribution Channel- Regional Outlook, Competitive Strategies and Segment Forecast to 2033' state that the Global Smart Insulin Pens Market is predicted to reach USD 2054.11 Million by 2033 with a CAGR of 10.69%.

Smart insulin pens provide an accessible option for exogenous insulin administration and diabetes treatment. It is a reusable injector pen that works with a simple app on a smartphone which allow for wireless data transfer to the app. This intelligent system keeps track of dosages and generates reports, useful notifications, and half-unit doses that are exact. In addition, it alerts patients whenever insulin is about to expire or reaches its temperature spectrum, allowing them to change the cartridge and provide diabetic information to the medical staff as needed.

There was a decrease in the number of prescriptions for smart insulin pens as a result of fewer patients visiting hospitals and diabetic centers during the COVID 19 pandemic. Additionally, the accessibility of these pens at retail stores was disrupted by problems in the delivery chain, which led to a decrease in sales. The pandemic-related economic slowdown made consumers more cost-conscious, which decreased the market for expensive connected insulin pens.

Scope of the Report:

Report Metric Details

Market size available for years 2020-2033

Base year considered 2023

Forecast period 2024-2033

Segments covered By Product, By Connectivity Type, By Application, By Distribution Channel

Regions covered North America, Asia-Pacific, Latin America, Middle East & Africa and Europe

Companies Covered Bigfoot Biomedical, Diamesco Co. Ltd., Eli Lilly and Company, Emperra GmbH, Jiangsu Deflu Medical Device Co. Ltd., Medtronic plc, Novo Nordisk A/S, Pendiq, Sanofi (Sanofi-Aventis US LLC), Ypsomed Holding AG, and others.

Smart Insulin Pens Market Segmentation

By Product: Based on the Product, Global Smart Insulin Pens Market is segmented as; Smart Insulin Pens, Adaptors for Conventional Pens

By Application: Based on the Application, Global Smart Insulin Pens Market is segmented as; Type 1 Diabetes, Type 2 Diabetes

By Distribution Channel: Based on the Distribution Channel, Global Smart Insulin Pens Market is segmented as; Hospital Pharmacies, Online Sales, Retail Pharmacies, Diabetes Clinics/Centers

1.Introduction

1.1.Scope of the report
1.2.Market segment analysis

2.Research Methodology

2.1.Research data source
- 2.1.1.Secondary Data
- 2.1.2.Primary Data
- 2.1.3.SPER's internal database
- 2.1.4.Premium insight from KOL's
2.2.Market size estimation
- 2.2.1.Top-down and Bottom-up approach
2.3.Data triangulation

3.Executive Summary

4.Market Dynamics

4.1.Driver, Restraint, Opportunity and Challenges analysis
- 4.1.1.Drivers
- 4.1.2.Restraints
- 4.1.3.Opportunities
- 4.1.4.Challenges
4.2.COVID-19 Impacts of the Global Smart Insulin Pens Market

5.Market variable and outlook

5.1.SWOT Analysis
- 5.1.1.Strengths
- 5.1.2.Weaknesses
- 5.1.3.Opportunities
- 5.1.4.Threats
5.2.PESTEL Analysis
- 5.2.1.Political Landscape
- 5.2.2.Economic Landscape
- 5.2.3.Social Landscape
- 5.2.4.Technological Landscape
- 5.2.5.Environmental Landscape
- 5.2.6.Legal Landscape
5.3.PORTER's Five Forces
- 5.3.1.Bargaining power of suppliers
- 5.3.2.Bargaining power of buyers
- 5.3.3.Threat of Substitute
- 5.3.4.Threat of new entrant
- 5.3.5.Competitive rivalry
5.4.Heat Map Analysis

6.Competitive Landscape

6.1.Global Smart Insulin Pens Market Manufacturing Base Distribution, Sales Area, Product Type
6.2.Mergers & Acquisitions, Partnerships, Product Launch, and Collaboration in Global Smart Insulin Pens Market

7.Global Smart Insulin Pens Market, By Product (USD Million)

7.1.Global Smart Insulin Pens Market Value Share and Forecast, By Product, 2024-2033
7.2.Smart Insulin Pens
7.3.Adaptors for Conventional Pens

8.Global Smart Insulin Pens Market, By Connectivity Type (USD Million)

8.1.Global Smart Insulin Pens Market Value Share and Forecast, By Connectivity Type, 2024-2033
8.2.Bluetooth
8.3.USB

9.Global Smart Insulin Pens Market, By Application (USD Million)

9.1.Global Smart Insulin Pens Market Value Share and Forecast, By Application, 2024-2033
9.2.Type 1 Diabetes
9.3.Type 2 Diabetes

10.Global Smart Insulin Pens Market, By Distribution Channel (USD Million)

10.1.Global Smart Insulin Pens Market Value Share and Forecast, By Distribution Channel, 2024-2033
10.2.Hospital Pharmacies
10.3.Online Sales
10.4.Retail Pharmacies
10.5.Diabetes Clinics/Centers

11.Global Smart Insulin Pens Market Forecast, 2020-2033 (USD Million)

11.1.Global Smart Insulin Pens Market Size and Market Share

12.Global Smart Insulin Pens Market, By Product Type 2020-2033 (USD Million)

12.1.Global Smart Insulin Pens Market Size and Market Share By Product (2020-2026)
12.2.Global Smart Insulin Pens Market Size and Market Share By Product (2027-2033)

13.Global Smart Insulin Pens Market, By Connectivity Type, 2020-2033 (USD Million)

13.1.Global Smart Insulin Pens Market Size and Market Share By Connectivity Type (2020-2026)
13.2.Global Smart Insulin Pens Market Size and Market Share By Connectivity Type (2027-2033)

14.Global Smart Insulin Pens Market, By Application, 2020-2033 (USD Million)

14.1.Global Smart Insulin Pens Market Size and Market Share By Application (2020-2026)
14.2.Global Smart Insulin Pens Market Size and Market Share By Application (2027-2033)

15.Global Smart Insulin Pens Market, By Distribution Channel, 2020-2033 (USD Million)

15.1.Global Smart Insulin Pens Market Size and Market Share By Distribution Channel (2020-2026)
15.2.Global Smart Insulin Pens Market Size and Market Share By Distribution Channel (2027-2033)

16.Global Smart Insulin Pens Market, By Region, 2020-2033 (USD Million)

16.1.Global Smart Insulin Pens Market Size and Market Share By Region (2020-2026)
16.2.Global Smart Insulin Pens Market Size and Market Share By Region (2027-2033)
16.3.Asia-Pacific
- 16.3.1.Australia
- 16.3.2.China
- 16.3.3.India
- 16.3.4.Japan
- 16.3.5.South Korea
- 16.3.6.Rest of Asia-Pacific
16.4.Europe
- 16.4.1.France
- 16.4.2.Germany
- 16.4.3.Italy
- 16.4.4.Spain
- 16.4.5.United Kingdom
- 16.4.6.Rest of Europe
16.5.Middle East and Africa
- 16.5.1.Kingdom of Saudi Arabia
- 16.5.2.United Arab Emirates
- 16.5.3.Rest of Middle East & Africa
16.6.North America
- 16.6.1.Canada
- 16.6.2.Mexico
- 16.6.3.United States
16.7.Latin America
- 16.7.1.Argentina
- 16.7.2.Brazil
- 16.7.3.Rest of Latin America

17.Company Profile

17.1.Bigfoot Biomedical
- 17.1.1.Company details
- 17.1.2.Financial outlook
- 17.1.3.Product summary
- 17.1.4.Recent developments
17.2.Diamesco Co. Ltd.
- 17.2.1.Company details
- 17.2.2.Financial outlook
- 17.2.3.Product summary
- 17.2.4.Recent developments
17.3.Eli Lilly and Company
- 17.3.1.Company details
- 17.3.2.Financial outlook
- 17.3.3.Product summary
- 17.3.4.Recent developments
17.4.Emperra GmbH
- 17.4.1.Company details
- 17.4.2.Financial outlook
- 17.4.3.Product summary
- 17.4.4.Recent developments
17.5.Jiangsu Deflu Medical Device Co. Ltd.
- 17.5.1.Company details
- 17.5.2.Financial outlook
- 17.5.3.Product summary
- 17.5.4.Recent developments
17.6.Medtronic plc
- 17.6.1.Company details
- 17.6.2.Financial outlook
- 17.6.3.Product summary
- 17.6.4.Recent developments
17.7.Novo Nordisk A/S
- 17.7.1.Company details
- 17.7.2.Financial outlook
- 17.7.3.Product summary
- 17.7.4.Recent developments
17.8.Pendiq
- 17.8.1.Company details
- 17.8.2.Financial outlook
- 17.8.3.Product summary
- 17.8.4.Recent developments
17.9.Sanofi (Sanofi-Aventis US LLC)
- 17.9.1.Company details
- 17.9.2.Financial outlook
- 17.9.3.Product summary
- 17.9.4.Recent developments
17.10.Ypsomed Holding AG
- 17.10.1.Company details
- 17.10.2.Financial outlook
- 17.10.3.Product summary
- 17.10.4.Recent developments
17.11.Others

한글목차

목차

제1장 서론

제2장 조사 방법

제3장 주요 요약

제4장 시장 역학

제5장 시장 변수와 전망

제6장 경쟁 구도

제7장 세계의 스마트 인슐린 펜 시장 : 제품별

제8장 세계의 스마트 인슐린 펜 시장 : 접속 유형별

제9장 세계의 스마트 인슐린 펜 시장 : 용도별

제10장 세계의 스마트 인슐린 펜 시장 : 유통 채널별

제11장 세계의 스마트 인슐린 펜 시장 예측

제12장 세계의 스마트 인슐린 펜 시장 : 제품 유형별

제13장 세계의 스마트 인슐린 펜 시장 : 접속 유형별

제14장 세계의 스마트 인슐린 펜 시장 : 용도별

제15장 세계의 스마트 인슐린 펜 시장 : 유통 채널별

제16장 세계의 스마트 인슐린 펜 시장 : 지역별

제17장 기업 개요

제18장 약어 리스트

제19장 참고 링크

제20장 결론

제21장 조사 범위